Comparative Pharmacology
Head-to-head clinical analysis: CYANOKIT versus SODIUM NITRITE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYANOKIT versus SODIUM NITRITE.
CYANOKIT vs SODIUM NITRITE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydroxocobalamin, a form of vitamin B12, acts as a scavenger of cyanide ions by binding with them to form cyanocobalamin, which is then excreted in urine. It has a higher affinity for cyanide than cytochrome c oxidase, thereby restoring mitochondrial function.
Sodium nitrite is a vasodilator that acts by relaxing vascular smooth muscle, primarily through the generation of nitric oxide (NO). It also converts hemoglobin to methemoglobin, which binds cyanide, thereby acting as an antidote for cyanide poisoning.
5 g intravenous infusion over 15 minutes for adults and pediatric patients weighing >=40 kg. A second dose of 5 g may be administered if needed based on clinical response.
300 mg (10 mL of a 30 mg/mL solution) intravenously over 2-4 minutes, followed immediately by sodium thiosulfate. May repeat once after 30-60 minutes if needed.
None Documented
None Documented
The terminal elimination half-life of hydroxocobalamin is approximately 24-28 hours in healthy adults; in cyanide poisoning, the half-life may be prolonged due to reversible binding to cyanide.
Terminal half-life: 0.5–1 hour (nitrite); due to rapid oxidation to nitrate, which has a half-life of 5–8 hours. Clinically, methemoglobin reduction requires monitoring for 2–4 hours.
Primarily renal elimination as hydroxocobalamin and cyanocobalamin; >90% of an intravenous dose is excreted in urine within 72 hours, with the remainder eliminated in feces via biliary excretion.
Primarily renal; 60-70% as nitrate and unchanged nitrite; minor biliary (<5%) and fecal (<2%) elimination.
Category C
Category C
Antidote
Antidote